Skip to main content

REVIEW article

Front. Endocrinol.
Sec. Pediatric Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1507749
This article is part of the Research Topic Disorders of Sex Development In Children: Advancing Multidisciplinary Approaches For Complex Diagnosis And Management View all articles

Profile of DHX37 gene defects in human genetic diseases: 46,XY disorders of sex development

Provisionally accepted
  • The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China

The final, formatted version of the article will be published soon.

    The RNA helicase DHX37 gene is involved in ribosomal biological processes, and linked to human genetic diseases associated with 46,XY disorders of sex development (46,XY DSD) or neurodevelopment. Recently, relevant reports have primarily focused on 46,XY DSD. However, there is still a lack of overall understanding of the genetic characteristics, phenotype, etc. of the DHX37 gene in human genetic diseases, and its molecular mechanism is not fully understood. We searched literature databases and summarized and analyzed all the literature related to DHX37 to date, including case reports, cohort studies, and molecular mechanism studies, to comprehensively demonstrate the role of DHX37 in human genetic diseases. Sixty patients were reported to have DHX37-related 46,XY DSD, with p.R308Q, p.R674W variants being the two most common mutation hotspots, accounting for 36.67% and 11.67% of cases respectively. In DSD cohorts, DHX37 gene mutations have different detection frequencies (0.77%-45.45%), whereas in testicular regression syndrome and 46,XY gonadal dysgenesis cohorts, they have a high detection rate. The gonadal development and fertility of female (46,XX) carriers with DHX37 gene mutations are not affected; however, incomplete penetrance may be observed in males (46,XY). The treatments are primarily surgical intervention and hormone replacement therapy administered at appropriate times; however, the long-term prognosis remains unknown. Although the molecular mechanism of DHX37 mutation related 46,XY DSD is unclear, ribosome synthesis, cell cycle regulation, and the NF-κB and Wnt pathways may be affected. This review summarizes the profile of DHX37 defects in human genetic diseases.DHX37 (NM_032656.4) belongs to the DexD/H-box RNA helicase family, a conserved protein group with an Asp-Glu-Ala-Asp motif (DEAD) (1). DHX37 is associated with 46,XY disorders of sex development (46,XY DSD; 46,XY sex reversal 11 in OMIM #273250) as autosomal dominant inheritance, and developmental delay ( "neurodevelopmental disorder with brain anomalies, with or without vertebral or cardiac anomalies" in OMIM #618731) as autosomal recessive inheritance (2, 3). We searched PubMed, Embase, and other literature databases and referred to the ClinVar gene

    Keywords: DHX37, 46, XY DSD, RNA helicase, human genetic diseases, genetic defects

    Received: 08 Oct 2024; Accepted: 22 Jan 2025.

    Copyright: © 2025 Peng, Peng, Chen, Hu, Zhang, Ma and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Huifang Peng, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
    Hongwei Jiang, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.